Learning Objectives:  

  • Deliver guideline-supported primary care for people with HIV
  • Discuss clinical eligibility for long-acting injectable cabotegravir/rilpivirine for HIV treatment
  • Discuss clinical eligibility and risks/benefits for long-acting injectable cabotegravir for HIV prevention 
     

Time & place 
Hybrid: Crosstown 2nd floor / Zoom 8 - 9am 

Presenter: Jessica Taylor, MD 
Faculty does not have any relevant financial relationships to disclose.

Session date: 
11/30/2022 - 8:00am to 9:00am EST
Location: 
Hybrid / Crosstown - Zoom
801 Mass Ave
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation

Please login or register to take this course.